Macrophages and depression – A misalliance or well-arranged marriage?
- 1 November 2013
- journal article
- review article
- Published by Springer Nature in Pharmacological Reports
- Vol. 65 (6) , 1663-1672
Abstract
Depression is a severe medical condition with multiple manifestations and diverse, largely unknown etiologies. The immune system, particularly macrophages, plays an important role in the pathology of the illness. Macrophages represent a heterogeneous population of immune cells that is dispersed throughout the body. The central nervous system is populated by several types of macrophages, including microglia, perivascular cells, meningeal and choroid plexus macrophages and pericytes. These cells occupy different brain compartments and have various functions. Under basal conditions, brain macrophages support the proper function of neural cells, organize and preserve the neuronal network and maintain homeostasis. As cells of the innate immune system, they recognize and react to any disturbances in homeostasis, eliminating pathogens or damaged cells, terminating inflammation and proceeding to initiate tissue reconstruction. Disturbances in these processes result in diverse pathologies. In particular, tissue stress or malfunction, both in the brain and in the periphery, produce sustained inflammatory states, which may cause depression. Excessive release of proinflammatory mediators is responsible for alterations of neurotransmitter systems and the occurrence of depressive symptoms. Almost all antidepressive drugs target monoamine or serotonin neurotransmission and also have anti-inflammatory or immunosuppressive properties. In addition, non-pharmacological treatments, such as electroconvulsive shock, can also exert anti-inflammatory effects. Recent studies have shown that antidepressive therapies can affect the functional properties of peripheral and brain macrophages and skew them toward the anti-inflammatory M2 phenotype. Because macrophages can affect outcome of inflammatory diseases, alleviate sickness behavior and improve cognitive function, it is possible that the effects of antidepressive treatments may be, at least in part, mediated by changes in macrophage activity.Keywords
Funding Information
- European Regional Development Fund (POIG.01.01.02-12-004/09)
This publication has 55 references indexed in Scilit:
- Microglia and monocyte-derived macrophages: functionally distinct populations that act in concert in CNS plasticity and repairFrontiers in Cellular Neuroscience, 2013
- Towards a glutamate hypothesis of depressionNeuropharmacology, 2012
- Cell atrophy and loss in depression: reversal by antidepressant treatmentCurrent Opinion in Cell Biology, 2011
- Macrophages make me sick: How macrophage activation states influence sickness behaviorPsychoneuroendocrinology, 2011
- Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on BehaviorNeuropsychopharmacology, 2011
- Alternatively activated myeloid (M2) cells enhance cognitive function in immune compromised miceBrain, Behavior, and Immunity, 2011
- Stress generation in depression: A systematic review of the empirical literature and recommendations for future studyClinical Psychology Review, 2010
- Sickness behavior induced by endotoxin can be mitigated by the dietary soluble fiber, pectin, through up-regulation of IL-4 and Th2 polarizationBrain, Behavior, and Immunity, 2010
- Cytokines and Glucocorticoid Receptor SignalingAnnals of the New York Academy of Sciences, 2009
- Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II studyPsychological Medicine, 2008